germline editing should be allowed, among them: “absence of reasonable alternatives, restriction to preventing a serious disease or condition,” and a few others that were not insurmountable in the foreseeable future.
Germline(in vivo) gene editing must only be ethically permitted in cases of preventing a congenital disease of the zygote, or "absence of any other relative alternative".
